Everest Organics Share Price
251.00+0.50 (+0.20%)
-38.32% past 1 Year
Corporate filings & documents
Announcements
Newspaper Publication of 33rd AGM and information relating to Remote Evoting
1 week agoNewspaper Publication of 33rd AGM and information relating to Remote Evoting
1 week ago33rd Annual Report for the FY 2025-26 is enclosed
1 week ago33rd Annual Report for the FY 2025-26 is enclosed
1 week agoNotice of 33rd Annual General Meeting of the Company along with 33rd Annual Report for the FY 2025-26 is enclosed
1 week agoNotice of 33rd Annual General Meeting of the Company along with 33rd Annual Report for the FY 2025-26 is enclosed
1 week agoNews Paper publications of Un-audited Financial Results for the Quarter ended June 30 2026
1 month agoNews Paper publications of Un-audited Financial Results for the Quarter ended June 30 2026
1 month agoEnclosed
1 month agoEnclosed
1 month agoEnclosed
1 month agoEnclosed
1 month agoEnclosed
1 month agoEnclosed
1 month agoAppointment of Mr. Subroto Banerjee as Additional Director of the Company in the Independent Category w.e.f. August 14 2026
1 month agoAppointment of Mr. Subroto Banerjee as Additional Director of the Company in the Independent Category w.e.f. August 14 2026
1 month agoAppointment of Mr. Srikanth Reddy Kolli as Additional Director in the Independent Category w.e.f. August 14 2026
1 month agoAppointment of Mr. Srikanth Reddy Kolli as Additional Director in the Independent Category w.e.f. August 14 2026
1 month agoEnclosed
1 month agoEnclosed
1 month agoEnclosed
1 month agoEnclosed
1 month agoEverest Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Board Meeting is scheduled to be held on Friday August 14 2026 to consider the business as mentioned in the attached Intimation.
1 month agoEverest Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Board Meeting is scheduled to be held on Friday August 14 2026 to consider the business as mentioned in the attached Intimation.
1 month agoThe Board of Directors approved by way of Circular Resolution on July 11 2026 the Allotment of 263157 fully paid-up equity shares of Rs. 10 each at a price of Rs. 152 each upon conversion of an equal number of convertible warrants held by Dr. Sirisha Srikakarlapudi Managing Director & Promoter of the Company on receipt of balance 75% consideration of Rs. 2 99 99 898.
2 months agoThe Board of Directors approved by way of Circular Resolution on July 11 2026 the Allotment of 263157 fully paid-up equity shares of Rs. 10 each at a price of Rs. 152 each upon conversion of an equal number of convertible warrants held by Dr. Sirisha Srikakarlapudi Managing Director & Promoter of the Company on receipt of balance 75% consideration of Rs. 2 99 99 898.
2 months agoIntimation of trading window closure for the quarter ended June 30 2026.
2 months agoIntimation of trading window closure for the quarter ended June 30 2026.
2 months agoResignation of Ms. Shweta Singh from the position of Company Secretary & Compliance Officer of the Company w.e.f. June 22 2026.
3 months agoResignation of Ms. Shweta Singh from the position of Company Secretary & Compliance Officer of the Company w.e.f. June 22 2026.
3 months agoNewspaper publication of Audited Financial Results for the quarter and year ended March 31 2026.
3 months agoAppointment of Mr. Narra Venkata Ramana as Additional Director in the Board Meeting held today i.e. May 29 2026.
3 months agoAppointment of Mr. Narra Venkata Ramana as Additional Director in the Board Meeting held today i.e. May 29 2026.
3 months agoOutcome of the Board Meeting held today .i.e. May 29 2026.
3 months agoOutcome of the Board Meeting held today .i.e. May 29 2026.
3 months agoAudited Financial Results for quarter and year ended March 31 2026.
3 months agoEnclosed the Annual Secretarial Compliance Report of the Company issued by M/s. RPR & Associates Practising Company Secretaries for the Fianancial Year ended March 31 2026.
4 months agoEnclosed the Annual Secretarial Compliance Report of the Company issued by M/s. RPR & Associates Practising Company Secretaries for the Fianancial Year ended March 31 2026.
4 months agoEverest Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve a) to consider and approve the Audited (Standalone) Financial Results of the Company for the quarter and year ended March 31 2026 b) to consider and take note of the draft Report of Statutory Auditor for the financial year ended March 31 2026.
4 months agoSubmission of certificate under Reg. 74(5) of SEBI (DP) Regulation for the quarter ended March 31 2026.
5 months agoSubmission of certificate under Reg. 74(5) of SEBI (DP) Regulation for the quarter ended March 31 2026.
5 months agoNewspaper publication- Special window for transfer and dematerialization of physical securities.
5 months agoNewspaper publication- Special window for transfer and dematerialization of physical securities.
5 months agoClosure of Trading Window
6 months agoClosure of Trading Window
6 months agoDisclosure of reason for delay in submission of financial results for the quarter ended December 31 2025.
6 months agoDisclosure of reason for delay in submission of financial results for the quarter ended December 31 2025.
6 months agoNewspaper Advertisement for publication of Unaudited financials results for the quarter and nine months ended December 31 2025
7 months agoEverest Organics Limited submitted the unaudited financial results for the quarter and nine months ended December 31 2025.
7 months agoEverest Organics Limited submitted exchange unaudited financials results for the quarter and nine months ended December 31 2025.
7 months agoAnnual reports
Concalls & investor presentations
No presentations found